LAMP3 and gastric adenocarcinoma: Interestingly, high expression of LAMP3 has a marked correlation with beneficial prognosis of READ patients for OS, and it has a marked correlation with good survival outcomes in patients with BRCA and STAD (all p < 0.05) (Figure 2R–T).